Sara Cannon Research Institute
Nashville, Tennessee 37203
We've found
1 trials
at this facility
Relapsed or Refractory Lymphoid Malignancies Clinical Trial
Updated: 2/26/2016
A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies
Status: Enrolling,
Phase
I
Updated: 2/26/2016
Click here to add this to my saved trials
